UBC-developed test for predicting lung attacks moves toward the market

The PROOF Centre, a group of UBC scientists focused on developing biomarkers for chronic organ disease, has granted a U.S. company exclusive rights to commercialize gene expression blood tests to help predict which patients with Chronic Obstructive Pulmonary Disease (COPD) are more likely to experience frequent “lung attacks.” For more information, click here.